M/s. Alish Life Saving Impex Pvt. Ltd.
Year of Incorporation:
September, 2008
Industry Sector:
Health Care
Products:
Medicines & Devices related to :
Legal Status:
Key Strengths:
Future Plans
Management of ALISH has major Expansion and Diversification plans chalked
out, and venturing fast into the manufacturing and distribution of affordable products
and devices to individual patients, institutions and organizations.
The company intends to import following range of critical products (Under License),
from the world leaders in Pharma Manufacturing from USA and other advanced
countries for Marketing in the Indian sub-continent.
Anti-Fungal Injectables
New drugs for Cancer related ailments
Post Radiation Skin Care products
Gastrology and Nephrology related products
Protein food items.
Demand outlook for its various products:
Company sees huge potential in Anti-Cancer drugs, Post Radiation skin care/
treatment drugs, Gastro and Nephro drugs. Most of the drugs are being present-
ly imported and hence they are expensive and the price prohibitive for Indian
markets. There is a scope for manufacturing of these branded drugs (Under Li-
cense) in India, which could make them affordable for the masses.
There is a huge demand for Food Supplements and High-Protein Food items.
India faces severe widespread malnutrition problems. These Food supplements
could be a great support to daily food and diet.
Exports:
The company is looking at various markets to develop the exports. The regions
of interest are Africa, South-East Asia, Middle-East, Sri Lanka, Bangladesh and
Nepal. Management is in process to shortlist Marketing Partners in the above
mentioned territories.